293 related articles for article (PubMed ID: 31768969)
1. The RNA Exosome and Human Disease.
Fasken MB; Morton DJ; Kuiper EG; Jones SK; Leung SW; Corbett AH
Methods Mol Biol; 2020; 2062():3-33. PubMed ID: 31768969
[TBL] [Abstract][Full Text] [Related]
2. The RNA exosome and RNA exosome-linked disease.
Morton DJ; Kuiper EG; Jones SK; Leung SW; Corbett AH; Fasken MB
RNA; 2018 Feb; 24(2):127-142. PubMed ID: 29093021
[TBL] [Abstract][Full Text] [Related]
3. A Drosophila model of Pontocerebellar Hypoplasia reveals a critical role for the RNA exosome in neurons.
Morton DJ; Jalloh B; Kim L; Kremsky I; Nair RJ; Nguyen KB; Rounds JC; Sterrett MC; Brown B; Le T; Karkare MC; McGaughey KD; Sheng S; Leung SW; Fasken MB; Moberg KH; Corbett AH
PLoS Genet; 2020 Jul; 16(7):e1008901. PubMed ID: 32645003
[TBL] [Abstract][Full Text] [Related]
4. Insight into the RNA Exosome Complex Through Modeling Pontocerebellar Hypoplasia Type 1b Disease Mutations in Yeast.
Fasken MB; Losh JS; Leung SW; Brutus S; Avin B; Vaught JC; Potter-Birriel J; Craig T; Conn GL; Mills-Lujan K; Corbett AH; van Hoof A
Genetics; 2017 Jan; 205(1):221-237. PubMed ID: 27777260
[TBL] [Abstract][Full Text] [Related]
5. A budding yeast model for human disease mutations in the
Sterrett MC; Enyenihi L; Leung SW; Hess L; Strassler SE; Farchi D; Lee RS; Withers ES; Kremsky I; Baker RE; Basrai MA; van Hoof A; Fasken MB; Corbett AH
RNA; 2021 Sep; 27(9):1046-1067. PubMed ID: 34162742
[TBL] [Abstract][Full Text] [Related]
6. Variants in EXOSC9 Disrupt the RNA Exosome and Result in Cerebellar Atrophy with Spinal Motor Neuronopathy.
Burns DT; Donkervoort S; Müller JS; Knierim E; Bharucha-Goebel D; Faqeih EA; Bell SK; AlFaifi AY; Monies D; Millan F; Retterer K; Dyack S; MacKay S; Morales-Gonzalez S; Giunta M; Munro B; Hudson G; Scavina M; Baker L; Massini TC; Lek M; Hu Y; Ezzo D; AlKuraya FS; Kang PB; Griffin H; Foley AR; Schuelke M; Horvath R; Bönnemann CG
Am J Hum Genet; 2018 May; 102(5):858-873. PubMed ID: 29727687
[TBL] [Abstract][Full Text] [Related]
7. In vivo characterization of the critical interaction between the RNA exosome and the essential RNA helicase Mtr4 in Saccharomyces cerevisiae.
Sterrett MC; Farchi D; Strassler SE; Boise LH; Fasken MB; Corbett AH
G3 (Bethesda); 2023 Aug; 13(8):. PubMed ID: 36861343
[TBL] [Abstract][Full Text] [Related]
8. Mutations in EXOSC2 are associated with a novel syndrome characterised by retinitis pigmentosa, progressive hearing loss, premature ageing, short stature, mild intellectual disability and distinctive gestalt.
Di Donato N; Neuhann T; Kahlert AK; Klink B; Hackmann K; Neuhann I; Novotna B; Schallner J; Krause C; Glass IA; Parnell SE; Benet-Pages A; Nissen AM; Berger W; Altmüller J; Thiele H; Weber BH; Schrock E; Dobyns WB; Bier A; Rump A
J Med Genet; 2016 Jun; 53(6):419-25. PubMed ID: 26843489
[TBL] [Abstract][Full Text] [Related]
9. RNA exosome mutations in pontocerebellar hypoplasia alter ribosome biogenesis and p53 levels.
Müller JS; Burns DT; Griffin H; Wells GR; Zendah RA; Munro B; Schneider C; Horvath R
Life Sci Alliance; 2020 Aug; 3(8):. PubMed ID: 32527837
[TBL] [Abstract][Full Text] [Related]
10. New subtype of PCH1C caused by novel EXOSC8 variants in a 16-year-old Spanish patient.
Rodríguez-García ME; Cotrina-Vinagre FJ; Bellusci M; Merino-López A; Chumilla-Calzada S; García-Silva MT; Martínez-Azorín F
Neuromuscul Disord; 2021 Aug; 31(8):773-782. PubMed ID: 34210538
[TBL] [Abstract][Full Text] [Related]
11. Bi-allelic missense variant, p.Ser35Leu in EXOSC1 is associated with pontocerebellar hypoplasia.
Somashekar PH; Kaur P; Stephen J; Guleria VS; Kadavigere R; Girisha KM; Bielas S; Upadhyai P; Shukla A
Clin Genet; 2021 Apr; 99(4):594-600. PubMed ID: 33463720
[TBL] [Abstract][Full Text] [Related]
12. Pontocerebellar Hypoplasia Type 1D: A Case Report and Comprehensive Literature Review.
Dabaj I; Hassani A; Burglen L; Qebibo L; Guerrot AM; Marret S; Tebani A; Bekri S
J Clin Med; 2022 Jul; 11(15):. PubMed ID: 35893425
[TBL] [Abstract][Full Text] [Related]
13. Recessive mutation in EXOSC3 associates with mitochondrial dysfunction and pontocerebellar hypoplasia.
Schottmann G; Picker-Minh S; Schwarz JM; Gill E; Rodenburg RJT; Stenzel W; Kaindl AM; Schuelke M
Mitochondrion; 2017 Nov; 37():46-54. PubMed ID: 28687512
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the RNA exosome component gene EXOSC3 cause pontocerebellar hypoplasia and spinal motor neuron degeneration.
Wan J; Yourshaw M; Mamsa H; Rudnik-Schöneborn S; Menezes MP; Hong JE; Leong DW; Senderek J; Salman MS; Chitayat D; Seeman P; von Moers A; Graul-Neumann L; Kornberg AJ; Castro-Gago M; Sobrido MJ; Sanefuji M; Shieh PB; Salamon N; Kim RC; Vinters HV; Chen Z; Zerres K; Ryan MM; Nelson SF; Jen JC
Nat Genet; 2012 Apr; 44(6):704-8. PubMed ID: 22544365
[TBL] [Abstract][Full Text] [Related]
15. Genetic and genomic studies of pathogenic EXOSC2 mutations in the newly described disease SHRF implicate the autophagy pathway in disease pathogenesis.
Yang X; Bayat V; DiDonato N; Zhao Y; Zarnegar B; Siprashvili Z; Lopez-Pajares V; Sun T; Tao S; Li C; Rump A; Khavari P; Lu B
Hum Mol Genet; 2020 Mar; 29(4):541-553. PubMed ID: 31628467
[TBL] [Abstract][Full Text] [Related]
16. Altered RNA metabolism due to a homozygous RBM7 mutation in a patient with spinal motor neuropathy.
Giunta M; Edvardson S; Xu Y; Schuelke M; Gomez-Duran A; Boczonadi V; Elpeleg O; Müller JS; Horvath R
Hum Mol Genet; 2016 Jul; 25(14):2985-2996. PubMed ID: 27193168
[TBL] [Abstract][Full Text] [Related]
17. Novel EXOSC9 variants cause pontocerebellar hypoplasia type 1D with spinal motor neuronopathy and cerebellar atrophy.
Sakamoto M; Iwama K; Sekiguchi F; Mashimo H; Kumada S; Ishigaki K; Okamoto N; Behnam M; Ghadami M; Koshimizu E; Miyatake S; Mitsuhashi S; Mizuguchi T; Takata A; Saitsu H; Miyake N; Matsumoto N
J Hum Genet; 2021 Apr; 66(4):401-407. PubMed ID: 33040083
[TBL] [Abstract][Full Text] [Related]
18. A Chemical Biology Approach to Model Pontocerebellar Hypoplasia Type 1B (PCH1B).
François-Moutal L; Jahanbakhsh S; Nelson ADL; Ray D; Scott DD; Hennefarth MR; Moutal A; Perez-Miller S; Ambrose AJ; Al-Shamari A; Coursodon P; Meechoovet B; Reiman R; Lyons E; Beilstein M; Chapman E; Morris QD; Van Keuren-Jensen K; Hughes TR; Khanna R; Koehler C; Jen J; Gokhale V; Khanna M
ACS Chem Biol; 2018 Oct; 13(10):3000-3010. PubMed ID: 30141626
[TBL] [Abstract][Full Text] [Related]
19. Pontocerebellar hypoplasia type 1 for the neuropediatrician: Genotype-phenotype correlations and diagnostic guidelines based on new cases and overview of the literature.
Ivanov I; Atkinson D; Litvinenko I; Angelova L; Andonova S; Mumdjiev H; Pacheva I; Panova M; Yordanova R; Belovejdov V; Petrova A; Bosheva M; Shmilev T; Savov A; Jordanova A
Eur J Paediatr Neurol; 2018 Jul; 22(4):674-681. PubMed ID: 29656927
[TBL] [Abstract][Full Text] [Related]
20. EXOSC3 mutations in pontocerebellar hypoplasia type 1: novel mutations and genotype-phenotype correlations.
Eggens VR; Barth PG; Niermeijer JM; Berg JN; Darin N; Dixit A; Fluss J; Foulds N; Fowler D; Hortobágyi T; Jacques T; King MD; Makrythanasis P; Máté A; Nicoll JA; O'Rourke D; Price S; Williams AN; Wilson L; Suri M; Sztriha L; Dijns-de Wissel MB; van Meegen MT; van Ruissen F; Aronica E; Troost D; Majoie CB; Marquering HA; Poll-Thé BT; Baas F
Orphanet J Rare Dis; 2014 Feb; 9():23. PubMed ID: 24524299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
